newheader.jpg
 


Conference Menu

Overview
Pre-Conference Events
Day 1
Day 2
Post-Conference Events 1
Post-Conference Events 2
PDF Download
Register
Hotel & Travel
Press Pass
Request Brochure
Send to a Colleague
 

Executive
Sponsor:

 

Premier
Sponsor:

 

Corporate
Sponsors:

 

Web Partners:

 
 

Post-Conference Events 1


2:30-6:00 RNAi End-User Forum*
* Separate registration is required. Participation is limited to end-users only and subject to approval by conference organizers. Companies with RNAi-related products or services on the market or in development (including sponsoring and exhibiting companies) will not receive access to the End-User Forum.

2:30-3:00 Participant Introductions

3:00-4:20 Discussion I: Strategies to Validate RNAi Data and Minimize Off-Target Effects
Discussion Leader: To Be Announced

Discussion Topics Include:
• How to increase specificity by using multiple siRNAs for each target and designing siRNAs with multiple mismatches with off-target       genes?
• How to choose siRNA delivery methods to maximize transfection, while minimizing toxicity and off-target effects?
• How to use scrambled siRNA as negative controls to account for siRNA delivery effects?
• How to “rescue” RNAi effect by expressing siRNA-resistant form of the gene?
• How to confirm siRNA specificity by monitoring global gene expression patterns?
• How to validate knockdown by montoring mRNA and protein levels?

4:20-4:40 Networking Refreshment Break

4:40-6:00 Discussion II: Overcoming Challenges in Applying RNAi for Target Identification and Validation
Discussion Leader: To Be Announced

Discussion Topics Include:
• Do RNAi technologies offer sufficient gene silencing specificity for target validation?
• What are the limitations in using siRNA for target validation given that it has a different mechanism of action than a small molecule?
• What are participants’ experiences in comparing siRNA and small molecule library screening?
• What other technologies should be combined with RNAi to increase confidence in “validated” targets?
• Do in vitro RNAi experiments provide a sufficiently good prediction of in vivo effect?
• What experimental design features increase confidence in siRNA-based target validation?

6:00 Close of RNAi End-User Forum

CO-LOCATED AT HIGH-CONTENT ANALYSIS 2006

2:00-7:00                        CONCURRENT USER GROUP MEETINGS
For more information or to register please visit www.highcontentanalysis.com.

E Healthcare - CHI IN Cell User Group Meeting

The GE Healthcare IN Cell user day will provide a stimulating forum for our IN Cell customers to present and discuss their work. Customers will get an insight into future plans and directions for the IN Cell platform and there will be open discussion sessions to capture any issues and new ideas.

 

More Imaging: New Options for the MDC Total Imaging Solution

Attend the First Annual MDC Imaging User Forum! At this user forum Molecular Devices will introduce the components of our Total High-content Imaging solution and announce several new developments! The forum will also include in-depth discussions of image acquisition and analysis software, imaging hardware options and turnkey assay-specific analysis modules from both end-users and MDC experts. High-content screening with fixed and live cell-based assays provides extensive multi-parametric cellular data. However, successful implementation or HCS requires a complete, turnkey environment from image acquisition through to data management. This forum will give attendees a complete perspective of HCS implementation. www.moleculardevices.com

 

Advanced Biological Exploration and Screening Using the BD Pathway Bioimager

This workshop will allow both users of the BD Pathway Bioimager and those interested in high content imaging to gather and discuss new applications and methods in imaging. The workshop will explore current topics in high content imaging and will introduce users to recent advances in hardware, software and reagents. A special emphasis will be given to assay development and advanced imaging techniques (e.g. kinetic and confocal imaging) to get the most out of automated imaging. 

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com